Loading company…
Tokyo company, founded in 2015, developing nucleic acid medicines and acting as a third-party drug delivery platform.
Founded in 2015 and based in Tokyo, Japan, Rena Therapeutics Inc. develops nucleic acid medicines. It acts as a third-party platform for delivering therapeutic drugs to users. The company is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in